Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Billi

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cancer Research|July 15, 1995
Phosphoinositide signaling in nuclei of Friend cells: tiazofurin down-regulates phospholipase C beta 1L Manzoli, A M Billi, R S Gilmour, et al.
Leukemia|August 22, 2003
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expressionA Cappellini, G Tabellini, M Zweyer, et al.
Cancer Research|November 21, 1998
Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cellsA Matteucci, I Faenza, R S Gilmour, et al.
Biochimica Et Biophysica Acta|April 13, 2000
Identification and chromosomal localisation by fluorescence in situ hybridisation of human gene of phosphoinositide-specific phospholipase C beta(1)D Peruzzi, G Calabrese, I Faenza, et al.
Leukemia|February 20, 2003
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulationR Bortul, P L Tazzari, A Cappellini, et al.
Leukemia|September 13, 2003
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cellsA M Martelli, P L Tazzari, G Tabellini, et al.
FEBS Letters|December 20, 2000
Insulin selectively stimulates nuclear phosphoinositide-specific phospholipase C (PI-PLC) beta1 activity through a mitogen-activated protein (MAP) kinase-dependent serine phosphorylationA M Martelli, A M Billi, L Manzoli, et al.
The Journal of Biological Chemistry|July 29, 2000
A role for nuclear phospholipase Cbeta 1 in cell cycle controlI Faenza, A Matteucci, L Manzoli, et al.
Biochimica Et Biophysica Acta|May 13, 1999
Inositides in the nucleus: presence and characterisation of the isozymes of phospholipase beta family in NIH 3T3 cellsL Cocco, S Rubbini, L Manzoli, et al.
Current Medicinal Chemistry|August 19, 2007
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedsideA M Martelli, P L Tazzari, C Evangelisti, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|July 15, 1995
Phosphoinositide signaling in nuclei of Friend cells: tiazofurin down-regulates phospholipase C beta 1L Manzoli, A M Billi, R S Gilmour, et al.
Leukemia|August 22, 2003
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expressionA Cappellini, G Tabellini, M Zweyer, et al.
Cancer Research|November 21, 1998
Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cellsA Matteucci, I Faenza, R S Gilmour, et al.
Biochimica Et Biophysica Acta|April 13, 2000
Identification and chromosomal localisation by fluorescence in situ hybridisation of human gene of phosphoinositide-specific phospholipase C beta(1)D Peruzzi, G Calabrese, I Faenza, et al.
Leukemia|February 20, 2003
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulationR Bortul, P L Tazzari, A Cappellini, et al.
Leukemia|September 13, 2003
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cellsA M Martelli, P L Tazzari, G Tabellini, et al.
FEBS Letters|December 20, 2000
Insulin selectively stimulates nuclear phosphoinositide-specific phospholipase C (PI-PLC) beta1 activity through a mitogen-activated protein (MAP) kinase-dependent serine phosphorylationA M Martelli, A M Billi, L Manzoli, et al.
The Journal of Biological Chemistry|July 29, 2000
A role for nuclear phospholipase Cbeta 1 in cell cycle controlI Faenza, A Matteucci, L Manzoli, et al.
Biochimica Et Biophysica Acta|May 13, 1999
Inositides in the nucleus: presence and characterisation of the isozymes of phospholipase beta family in NIH 3T3 cellsL Cocco, S Rubbini, L Manzoli, et al.
Current Medicinal Chemistry|August 19, 2007
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedsideA M Martelli, P L Tazzari, C Evangelisti, et al.
Pageof 5